Common Contracts
2 similar Collaboration Agreement contracts by Seattle Genetics Inc /Wa, Takeda Pharmaceutical Co LTD
COLLABORATION AGREEMENTCollaboration Agreement • November 16th, 2018 • Takeda Pharmaceutical Co LTD • Pharmaceutical preparations • New York
This COLLABORATION AGREEMENT (the “Agreement”) is entered into on December 14, 2009 (the “Effective Date”) by and between Seattle Genetics, Inc., a Delaware corporation, with its principal place of business at 21823 30th Drive SE, Bothell, WA 98021 (“SGI”), and Millennium Pharmaceuticals, Inc., with its principal place of business at 40 Landsdowne Street, Cambridge, MA 02139 (“MPI”). SGI and MPI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
COLLABORATION AGREEMENTCollaboration Agreement • March 12th, 2010 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
This COLLABORATION AGREEMENT (the “Agreement”) is entered into on December 14, 2009 (the “Effective Date”) by and between Seattle Genetics, Inc., a Delaware corporation, with its principal place of business at 21823 30th Drive SE, Bothell, WA 98021 (“SGI”), and Millennium Pharmaceuticals, Inc., with its principal place of business at 40 Landsdowne Street, Cambridge, MA 02139 (“MPI”). SGI and MPI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
